Morgan Stanley’s Pharvaris PHVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Sell |
59,772
-15,593
| -21% | -$274K | ﹤0.01% | 5066 |
|
|
2025
Q1 | $1.18M | Buy |
75,365
+48,368
| +179% | +$759K | ﹤0.01% | 4929 |
|
|
2024
Q4 | $518K | Buy |
26,997
+2,746
| +11% | +$52.6K | ﹤0.01% | 5402 |
|
|
2024
Q3 | $449K | Buy |
24,251
+955
| +4% | +$17.7K | ﹤0.01% | 5454 |
|
|
2024
Q2 | $438K | Sell |
23,296
-5,745
| -20% | -$108K | ﹤0.01% | 5350 |
|
|
2024
Q1 | $671K | Sell |
29,041
-15,935
| -35% | -$368K | ﹤0.01% | 5177 |
|
|
2023
Q4 | $1.26M | Buy |
44,976
+11,279
| +33% | +$316K | ﹤0.01% | 5193 |
|
|
2023
Q3 | $703K | Sell |
33,697
-11,635
| -26% | -$243K | ﹤0.01% | 4994 |
|
|
2023
Q2 | $686K | Sell |
45,332
-3,653
| -7% | -$55.3K | ﹤0.01% | 5051 |
|
|
2023
Q1 | $395K | Buy |
48,985
+10,805
| +28% | +$87K | ﹤0.01% | 5394 |
|
|
2022
Q4 | $430K | Buy |
38,180
+19,085
| +100% | +$215K | ﹤0.01% | 5319 |
|
|
2022
Q3 | $146K | Buy |
19,095
+2,279
| +14% | +$17.4K | ﹤0.01% | 5891 |
|
|
2022
Q2 | $372K | Buy |
16,816
+631
| +4% | +$14K | ﹤0.01% | 5570 |
|
|
2022
Q1 | $294K | Sell |
16,185
-2,071
| -11% | -$37.6K | ﹤0.01% | 5707 |
|
|
2021
Q4 | $262K | Buy |
18,256
+709
| +4% | +$10.2K | ﹤0.01% | 5917 |
|
|
2021
Q3 | $311K | Sell |
17,547
-2,437
| -12% | -$43.2K | ﹤0.01% | 5761 |
|
|
2021
Q2 | $372K | Buy |
19,984
+15,149
| +313% | +$282K | ﹤0.01% | 5702 |
|
|
2021
Q1 | $135K | Buy |
+4,835
| New | +$135K | ﹤0.01% | 5866 |
|